Defibrotide for the treatment of severe hepatic veno-occlusive disease in hematopoietic stem cell transplant patients: A historically-controlled, multi-center phase 3 st
|Effective start/end date||6/1/06 → 2/1/11|
- GENTIUM SPA
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.